Illinois Municipal Retirement Fund lifted its stake in shares of DaVita Inc. (NYSE:DVA – Free Report) by 97.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 6,753 shares of the company’s stock after acquiring an additional 3,340 shares during the period. Illinois Municipal Retirement Fund’s holdings in DaVita were worth $1,181,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the stock. CoreCap Advisors LLC boosted its holdings in shares of DaVita by 161.7% in the 3rd quarter. CoreCap Advisors LLC now owns 157 shares of the company’s stock valued at $27,000 after purchasing an additional 97 shares during the last quarter. Provenance Wealth Advisors LLC purchased a new stake in DaVita during the third quarter valued at about $30,000. Western Wealth Management LLC acquired a new stake in DaVita during the first quarter worth about $60,000. Compass Financial Management LLC purchased a new position in shares of DaVita in the 2nd quarter worth about $72,000. Finally, Cassaday & Co Wealth Management LLC purchased a new position in shares of DaVita in the 1st quarter worth about $79,000. 90.12% of the stock is currently owned by hedge funds and other institutional investors.
DaVita Price Performance
NYSE DVA opened at $173.14 on Wednesday. DaVita Inc. has a 12 month low of $101.00 and a 12 month high of $247.49. The company has a market capitalization of $10.89 billion, a price-to-earnings ratio of 12.75, a price-to-earnings-growth ratio of 0.44 and a beta of 0.87. The company’s fifty day moving average price is $182.23 and its two-hundred day moving average price is $181.08.
DaVita (NYSE:DVA – Get Free Report) last released its earnings results on Thursday, October 29th. The company reported $3.82 earnings per share for the quarter, topping the consensus estimate of $3.57 by $0.25. DaVita had a net margin of 6.49% and a negative return on equity of 225.93%. The company had revenue of $3.58 billion during the quarter, compared to the consensus estimate of $3.52 billion. During the same quarter in the previous year, the firm earned $2.51 EPS. The company’s revenue was up 4.6% on a year-over-year basis. As a group, analysts anticipate that DaVita Inc. will post 14.66 EPS for the current year.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the stock. Wall Street Zen downgraded shares of DaVita from a “buy” rating to a “hold” rating in a research report on Saturday, October 31st. UBS Group raised their price objective on DaVita from $270.00 to $287.00 and gave the company a “buy” rating in a research report on Monday, November 2nd. Weiss Ratings raised DaVita from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, October 9th. Barclays dropped their target price on DaVita from $224.00 to $216.00 and set an “equal weight” rating on the stock in a report on Monday, November 2nd. Finally, TD Cowen upped their price target on DaVita from $220.00 to $228.00 and gave the stock a “buy” rating in a report on Monday, November 2nd. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $235.86.
Get Our Latest Analysis on DaVita
DaVita Company Profile
DaVita Inc. is a healthcare provider focused on kidney care. Its core business is operating outpatient dialysis centers that provide treatment and related services to people with chronic kidney failure. The company also offers home dialysis programs, provides dialysis services to patients in hospitals, and supports kidney care through services such as care coordination and education. DaVita primarily serves patients in the United States and also operates in international markets. Founded in 1994 as Total Renal Care, the company adopted the name DaVita in 2000.
Read More
- Five stocks we like better than DaVita
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
